Perfusion Systems Market to Hit 3.9% CAGR and Projected to Cross US$ 1,198.8 Million by 2021
Cell perfusion systems market is segmented based on type, as bioreactor perfusion systems, micro fluidic perfusion systems, gravity or pressure-driven perfusion systems, and small-mammal organ perfusion systems. Bioreactor perfusion systems segment held l
(EMAILWIRE.COM, October 05, 2018 ) Perfusion systems market is projected to reach USD 1,198.8 million by 2021, at a CAGR of 3.9% during forecast period 2016-2021. Growth of market can be attributed to increasing prevalence of cardiovascular and respiratory diseases, initiatives by governments and NGOs to encourage organ donation, increasing investment in cell-based research, and developments in biologics manufacturing.
Access the Sample Copy of Perfusion Systems Market spread across 152 Pages, Profiling 13 Companies and Supported with 74 Tables and 61 Figures is now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=972927 .
Report studies factors affecting growth of perfusion systems market and analyzes opportunities and challenges in the market for stakeholders. It provides details of the competitive landscape of market leaders and analyzes micro-markets on their individual growth trends, prospects, and contributions to the total market. Report forecasts revenue of market segments with respect to four main regions.
Target Audience:
Perfusion systems and related devices manufacturing companies
Suppliers and distributors of perfusion systems and components
Organ preservation and devices providers
Hospitals, medical colleges, biopharmaceutical industries, R&D institutes
Teaching hospitals and academic medical centers (AMCs)
Government bodies and regulatory authorities
Business research and consulting service providers
Venture capitalists
Geographically, North America is estimated to account for largest share of global market, followed by Europe. Asia-Pacific region is expected to witness highest growth in market during forecast period. This growth will be particularly centered on China, Japan, and India. Hypothermic machine perfusion segment accounted for largest share of market in 2016 and is also projected to grow at the highest CAGR during the forecast period.
Click now for more information on the perfusion systems market research now at <||>rnhttp://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=972927 .
Global cell perfusion systems market is segmented based on type, as bioreactor perfusion systems, microfluidic perfusion systems, gravity or pressure-driven perfusion systems, and small-mammal organ perfusion systems. Bioreactor perfusion systems segment held largest share of cell perfusion systems market in 2016 and is projected to register the highest CAGR during the forecast period.
Competitive Landscape
1 Introduction
2 Vanguards
3 Innovator
4 Dynamic
5 Emerging
6 Competitive Benchmarking
7 Product Offerings
8 Business Strategy
Major players in cardiopulmonary perfusion systems market include Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), and XENIOS AG (Germany). The major players in the ex vivo organ perfusion systems market are Lifeline Scientific, Inc. (U.S.) and XVIVO Perfusion AB (Sweden), while, Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), and ALA Scientific Instruments, Inc. (U.S.) are some of the leading players in the cell perfusion systems market.
Connect for More Details for Discount and More Information Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Heart-lung Machines, Oxygenators), Ex Vivo Organ Perfusion, Technique (Hypothermic, Normothermic), Cell Perfusion, by Type (Bioreactor, Microfluidic)) - Global Forecast to 2021 report @ http://www.reportsnreports.com/contacts/discount.aspx?name=972927 .
The perfusion systems market is segmented on the basis of type (namely cardiopulmonary perfusion systems, ex vivo organ perfusion systems, and cell perfusion systems) and region. The global cardiopulmonary perfusion systems market is segmented based on components into oxygenators, heart-lung machines, perfusion pumps, cannulas, monitoring systems, and other components
Access the Sample Copy of Perfusion Systems Market spread across 152 Pages, Profiling 13 Companies and Supported with 74 Tables and 61 Figures is now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=972927 .
Report studies factors affecting growth of perfusion systems market and analyzes opportunities and challenges in the market for stakeholders. It provides details of the competitive landscape of market leaders and analyzes micro-markets on their individual growth trends, prospects, and contributions to the total market. Report forecasts revenue of market segments with respect to four main regions.
Target Audience:
Perfusion systems and related devices manufacturing companies
Suppliers and distributors of perfusion systems and components
Organ preservation and devices providers
Hospitals, medical colleges, biopharmaceutical industries, R&D institutes
Teaching hospitals and academic medical centers (AMCs)
Government bodies and regulatory authorities
Business research and consulting service providers
Venture capitalists
Geographically, North America is estimated to account for largest share of global market, followed by Europe. Asia-Pacific region is expected to witness highest growth in market during forecast period. This growth will be particularly centered on China, Japan, and India. Hypothermic machine perfusion segment accounted for largest share of market in 2016 and is also projected to grow at the highest CAGR during the forecast period.
Click now for more information on the perfusion systems market research now at <||>rnhttp://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=972927 .
Global cell perfusion systems market is segmented based on type, as bioreactor perfusion systems, microfluidic perfusion systems, gravity or pressure-driven perfusion systems, and small-mammal organ perfusion systems. Bioreactor perfusion systems segment held largest share of cell perfusion systems market in 2016 and is projected to register the highest CAGR during the forecast period.
Competitive Landscape
1 Introduction
2 Vanguards
3 Innovator
4 Dynamic
5 Emerging
6 Competitive Benchmarking
7 Product Offerings
8 Business Strategy
Major players in cardiopulmonary perfusion systems market include Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), and XENIOS AG (Germany). The major players in the ex vivo organ perfusion systems market are Lifeline Scientific, Inc. (U.S.) and XVIVO Perfusion AB (Sweden), while, Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), and ALA Scientific Instruments, Inc. (U.S.) are some of the leading players in the cell perfusion systems market.
Connect for More Details for Discount and More Information Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Heart-lung Machines, Oxygenators), Ex Vivo Organ Perfusion, Technique (Hypothermic, Normothermic), Cell Perfusion, by Type (Bioreactor, Microfluidic)) - Global Forecast to 2021 report @ http://www.reportsnreports.com/contacts/discount.aspx?name=972927 .
The perfusion systems market is segmented on the basis of type (namely cardiopulmonary perfusion systems, ex vivo organ perfusion systems, and cell perfusion systems) and region. The global cardiopulmonary perfusion systems market is segmented based on components into oxygenators, heart-lung machines, perfusion pumps, cannulas, monitoring systems, and other components
Contact Information:
ReportsnReports
Mr. Hrishikesh
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Mr. Hrishikesh
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results